Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.

Prostate cancer and prostatic diseases - 1 Sept 2012

Li X-L, Xu J-H

Abstract excerpt

BACKGROUND: 5,10-Methylenetetrahydrofolate reductase (MTHFR) polymorphisms implicated in the cancer development, but the published studies had yielded inconsistent results. METHODS: Pubmed was searched for all published case-control studies about MTHFR polymorphisms and prostate cancer risk. RESULTS: In all, 13 studies including 5872 cases and 6255 controls described C677T genotypes, among which 9 articles,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Predisposition to Disease
Share to Inheritance Patterns

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Odds Ratio

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 22370724
DOI: 10.1038/pcan.2012.5

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case-control studies.PMID 22370724Read ↗

MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls.Semantic proximity Read ↗

Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.Semantic proximity Read ↗

Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.Semantic proximity Read ↗

The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls.Semantic proximity Read ↗

Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.Semantic proximity Read ↗

The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.Semantic proximity Read ↗

Effects of the MTHFR C677T polymorphism on prostate specific antigen and prostate cancer.Semantic proximity Read ↗

Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in taiwan.Semantic proximity Read ↗

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.Semantic proximity Read ↗

MTHFR c.677C>T Inhibits Cell Proliferation and Decreases Prostate Cancer Susceptibility in the Han Chinese Population in Shanghai.Semantic proximity Read ↗

Analysis of relation between C677T genotype in MTHFR gene and prostatic cancer in Iranian males.Semantic proximity Read ↗

Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.